Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain:: D620E and E627E

被引：65

作者：

Schnittger, S. ^{[1
]}

Bacher, U.

Kern, W.

Schroeder, M.

Haferlach, T.

Schoch, C.

机构：

[1] Munich Leukemia Lab, Munich, Germany

[2] Univ Hosp Munich, Dept Clin Chem, Munich, Germany

[3] Vinzentius Krankenhaus, Landau, Germany

来源：

LEUKEMIA | 2006年 / 20卷 / 12期

关键词：

D O I：

10.1038/sj.leu.2404325

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2195 / 2197

页数：4

共 8 条

[1]

Jaffe E.S., 2001, PATHOLOGY GENETICS T, V3

[2] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].

James, C ;

Ugo, V ;

Le Couédic, JP ;

Staerk, J ;

Delhommeau, F ;

Lacout, C ;

Garçon, L ;

Raslova, H ;

Berger, R ;

Bennaceur-Griscelli, A ;

Villeval, JL ;

Constantinescu, SN ;

Casadevall, N ;

Vainchenker, W .

NATURE, 2005, 434 (7037) :1144-1148

[3] Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders [J].

Jones, AV ;

Kreil, S ;

Zoi, K ;

Waghorn, K ;

Curtis, C ;

Zhang, LY ;

Score, J ;

Seear, R ;

Chase, AJ ;

Grand, FH ;

White, H ;

Zoi, C ;

Loukopoulos, D ;

Terpos, E ;

Vervessou, EC ;

Schultheis, B ;

Emig, M ;

Ernst, T ;

Lengfelder, E ;

Hehlmann, R ;

Hochhaus, A ;

Oscier, D ;

Silver, RT ;

Reiter, A ;

Cross, NCP .

BLOOD, 2005, 106 (06) :2162-2168

[4] A gain-of-function mutation of JAK2 in myeloproliferative disorders [J].

Kralovics, R ;

Passamonti, F ;

Buser, AS ;

Teo, S ;

Tiedt, R ;

Passweg, JR ;

Tichelli, A ;

Cazzola, M ;

Skoda, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) :1779-1790

[5] The JAK2 V617F mutation in de novo acute myelogenous leukemias [J].

Lee, JW ;

Kim, YG ;

Soung, YH ;

Han, KJ ;

Kim, SY ;

Rhim, HS ;

Min, WS ;

Nam, SW ;

Park, WS ;

Lee, JY ;

Yoo, NJ ;

Lee, SH .

ONCOGENE, 2006, 25 (09) :1434-1436

[6] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis [J].

Levine, RL ;

Wadleigh, M ;

Cools, J ;

Ebert, BL ;

Wernig, G ;

Huntly, BJP ;

Boggon, TJ ;

Wlodarska, L ;

Clark, JJ ;

Moore, S ;

Adelsperger, J ;

Koo, S ;

Lee, JC ;

Gabriel, S ;

Mercher, T ;

D'Andrea, A ;

Fröhling, S ;

Döhner, K ;

Marynen, P ;

Vandenberghe, P ;

Mesa, RA ;

Tefferi, A ;

Griffin, JD ;

Eck, MJ ;

Sellers, WR ;

Meyerson, M ;

Golub, TR ;

Lee, SJ ;

Gilliland, DG .

CANCER CELL, 2005, 7 (04) :387-397

[7] Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation [J].

Lindauer, K ;

Loerting, T ;

Liedl, KR ;

Kroemer, RT .

PROTEIN ENGINEERING, 2001, 14 (01) :27-37

[8] Regulation of the Jak2 tyrosine kinase by its pseudokinase domain [J].

Saharinen, P ;

Takaluoma, K ;

Silvennoinen, O .

MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (10) :3387-3395

← 1 →